Tampa Federal Pharmacy Fraud Lawyer

Federal pharmacy fraud prosecutions move fast, and they are built on evidence that investigators have often spent months or years assembling before a single arrest is made. By the time a pharmacist, pharmacy owner, prescriber, or billing specialist hears from federal agents, the government already believes it has a case. What happens next depends entirely on the quality of the defense that meets it. Daniel J. Fernandez has spent 43 years defending clients in federal and state courts across Florida, including cases where healthcare billing and prescription drug allegations formed the core of the charges. His background as a former prosecutor means he understands how the Department of Justice and its agency partners build these cases, and he uses that knowledge on behalf of the people sitting across from him at the defense table. This page explains what Tampa federal pharmacy fraud charges actually look like, what drives the government’s investigation decisions, and what an aggressive federal defense can accomplish.

How Federal Pharmacy Fraud Charges Actually Get Built

Most federal pharmacy fraud investigations do not start with a single dramatic tip. They begin with data. The Centers for Medicare and Medicaid Services, the Department of Health and Human Services Office of Inspector General, and the DEA all run analytics programs that flag billing patterns deviating from statistical norms. A pharmacy in Tampa billing at rates significantly above regional peers, a prescriber whose patients fill controlled substances at unusually high rates, or a practice generating claims for medications that were never dispensed, all of these show up in federal databases long before an investigator knocks on anyone’s door.

Once the data triggers an audit or referral, agents from the FBI, DEA, or HHS-OIG typically begin building the case in the background. That can mean reviewing years of pharmacy dispensing records obtained from state prescription drug monitoring programs, executing subpoenas for billing records, interviewing employees without telling them the true scope of the investigation, and sometimes placing cooperating informants. By the time a target receives a grand jury subpoena or learns that a search warrant has been executed on the pharmacy’s records, the investigation is usually well advanced.

The federal charges that follow vary based on the specific conduct alleged. Healthcare fraud under 18 U.S.C. Section 1347 is the most common vehicle, often coupled with wire fraud or mail fraud allegations based on the electronic transmission of claims. Cases involving controlled substances frequently add charges under the Controlled Substances Act. The False Claims Act provides a parallel civil track that can produce enormous financial penalties even when criminal charges are not pursued. Conspiracy counts are almost always included, because they allow prosecutors to hold each participant responsible for the acts of the others, which can dramatically expand exposure for people who played smaller roles in a larger operation.

Who Gets Charged and Why Peripheral Involvement Is Not a Defense Without the Right Representation

Federal pharmacy fraud prosecutions cast a wide net. The pharmacy owner who set up the billing practices is an obvious target. Less obvious are the pharmacists who processed prescriptions they had reason to question, the billing staff who submitted claims they did not fully understand, the prescribers who signed off on orders for patients they rarely or never examined, and the marketing representatives who paid referral fees in exchange for business. All of them can end up in the same indictment.

In the Tampa Bay federal court system, the Sam M. Gibbons United States Courthouse handles these prosecutions, and the Middle District of Florida is one of the more active federal districts in the country when it comes to healthcare fraud enforcement. Florida’s large Medicare and Medicaid population, combined with a historically high concentration of pain management clinics and specialty pharmacies in the region, has made the Middle District a focus of healthcare fraud task forces for many years.

A person who processed claims without knowing they were fraudulent is in a different legal position than someone who designed the scheme, but federal prosecutors do not always draw those lines clearly in the initial indictment. The government’s charging decisions are made based on what evidence they have assembled, and the incentive structure of federal prosecution encourages broad charging followed by pressure to cooperate. A pharmacist or billing employee who believes they are a minor participant may still be looking at a federal felony conviction and potential prison time if they do not have counsel who knows how to challenge the government’s characterization of their role.

The Specific Defenses That Matter in These Cases

Federal healthcare fraud requires proof of intent. That is not a technicality. Pharmacy billing is genuinely complex. Coverage rules change. Formularies differ by plan. Proper dispensing practices for compounded medications, for durable medical equipment associated with prescriptions, and for certain controlled substance protocols are legitimately disputed in ways that create real ambiguity. A defense built on the honest complexity of billing compliance is not the same as claiming ignorance. It is a factual and legal argument that the government has not proved that the defendant knowingly submitted false claims.

Beyond intent, the defense often targets the government’s documentation. Pharmacy records, dispensing logs, and billing data can be reconstructed and reanalyzed. Government data analysts make mistakes. Billing codes have multiple interpretations. A prescription that appeared on paper to lack validity may have had legitimate clinical support that investigators overlooked or did not seek out. Defense experts in pharmacy practice, healthcare compliance, and medical billing are often essential to presenting this analysis to a jury in the Middle District.

Sentencing also requires serious attention from the beginning of a federal case. Federal pharmacy fraud sentences are driven by loss calculations under the United States Sentencing Guidelines. The government’s proposed loss figure is almost always contested, because it drives the guideline range more than almost any other single factor. A difference of a few hundred thousand dollars in the loss calculation can mean years of difference in the sentencing range. Challenging the loss amount, demonstrating the absence of specific intended loss, or establishing the defendant’s minor role all carry concrete consequences that start being built at the investigative stage, not at sentencing.

Questions People Ask When They First Call About a Pharmacy Fraud Investigation

Federal agents contacted me but have not arrested me. Should I speak with them?

No. Federal agents who contact a pharmacy owner, pharmacist, or employee as part of a fraud investigation are gathering evidence, not offering an opportunity to clear things up. Anything said in that conversation can be used against the speaker, and the interview itself can create additional exposure if statements are later characterized as false or misleading. Retaining defense counsel before any contact with investigators is the right move.

My pharmacy received a subpoena for records. Does that mean I am under investigation?

A grand jury subpoena for business records is a signal that the government is building a case, and your pharmacy or your practice is inside the scope of that investigation. The subpoena itself is a legal process that must be handled carefully, because how you respond, what you produce, and whether any records are withheld all have consequences. Defense counsel should be involved immediately.

What is the difference between a civil False Claims Act case and a criminal pharmacy fraud prosecution?

Criminal prosecution requires proof beyond a reasonable doubt and can result in prison time. A civil False Claims Act case proceeds under a lower burden of proof and results in financial penalties, typically three times the alleged false claims plus additional per-claim penalties. The government can and does pursue both tracks simultaneously. Some False Claims Act cases are also initiated by whistleblowers, including current or former employees, through what are called qui tam actions.

If I receive a DEA notice of inspection or a Medicare audit, is that different from a criminal investigation?

Regulatory inspections and audits can be routine, but they can also be part of a parallel track running alongside a criminal or civil investigation. Information gathered in an administrative audit can be shared with law enforcement. A pharmacy that responds to an audit without counsel may be providing evidence it does not realize it is providing.

How long do federal pharmacy fraud investigations typically take before charges are filed?

These investigations frequently run one to three years before a target knows they are under scrutiny. By the time an indictment is returned, the government has usually reviewed years of billing records and interviewed multiple witnesses. The extended timeline is one reason it is so critical to act quickly once any contact from federal agents or regulators occurs.

Can a pharmacist lose their license as a result of a federal fraud charge?

Yes. A federal conviction for healthcare fraud or a controlled substance violation carries licensing consequences that are separate from the criminal sentence. Florida’s Department of Health and the Board of Pharmacy have their own disciplinary processes, and a federal charge, even before conviction, can trigger a license review. Defense strategy must account for both the criminal and the administrative tracks at the same time.

What happens to a pharmacy’s ability to bill Medicare or Medicaid while charges are pending?

Federal healthcare fraud charges can trigger exclusion from Medicare and Medicaid programs, sometimes even before a case is resolved. The HHS-OIG maintains a list of excluded providers, and billing from an excluded provider can itself create new liability. This is one of the most immediate practical consequences of a federal pharmacy fraud charge, and it requires attention from the first day of representation.

Representation for Federal Pharmacy Fraud Charges Across the Middle District of Florida

The Law Office of Daniel J. Fernandez, P.A. represents clients across Tampa Bay and throughout the Middle District of Florida in federal criminal matters, including pharmacy fraud, healthcare billing fraud, and related controlled substance prosecutions. Daniel J. Fernandez has personally tried more than 500 cases to verdict over his 43-year career and brings a former prosecutor’s understanding of how the government builds its cases to every federal defense he handles. Whether a federal pharmacy fraud investigation is just beginning or charges have already been filed, the right representation for Tampa federal pharmacy fraud matters is the kind built from deep familiarity with the federal system, the courts, and the specific evidence challenges these cases present.